LONDON UNITED KINGDOM Marketwired 010818 TopiVert Pharma Ltd TopiVert announces positive results from the Phase 1 study with its oral formulation of TOP1288 for the treatment of ulcerative colitis London UK 8 January 2018 TopiVert Pharma Ltd "Top...
↧